CASCINU, Stefano

CASCINU, Stefano  

Dipartimento Scienze Cliniche e Molecolari  

Mostra records
Risultati 1 - 20 di 280 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
5-Fluorouracil, leucovorin and interferon alpha 2b in advanced pancreatic cancer: a pilot study. 1-gen-1993 Cascinu, Stefano; A., Fedeli; S. L., Fedeli; G., Catalano
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas 1-gen-2014 Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Polonara, Gabriele; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Berardi, Rossana; Stefano, Fanti; Cascinu, Stefano
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). 1-gen-2000 Cascinu, Stefano; L., Frontini; R., Labianca; V., Catalano; S., Barni; C., Graiff; G., Picone; E., Farinati; S., Zonato; M. A., Pessi; C., Curti; G., Catalano
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation. 1-gen-2008 Cascinu, Stefano; Berardi, Rossana; Salvagni, S; Beretta, Gd; Catalano, V; Pucci, F; Sobrero, A; Tagliaferri, P; Labianca, R; Scartozzi, M; Crocicchio, F; Mari, E; Ardizzoni, A.
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). 1-gen-1999 Cascinu, Stefano; R. R., Silva; S., Barni; R., Labianca; L., Frontini; E., Piazza; G., Pancera; P., Giordani; L., Giuliodori; M. A., Pessi; V., Fusco; G., Luporini; Cellerino, Riccardo; G., Catalano
A cost-benefit analysis of chemotherapy for gastric cancer. 1-gen-2004 Galizia, E; Berardi, Rossana; Scartozzi, M; Cascinu, Stefano
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma. 1-gen-2008 M., Reni; Berardi, Rossana; A., Mambrini; L., Pasetto; S., Cereda; V. D., Ferrari; Cascinu, Stefano; M., Cantore; E., Mazza; S., Grisanti
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 1-gen-2012 Campanati, Anna; Berardi, Rossana; Onofri, Azzurra; Pierantoni, C.; Conte, I.; Giuliodori, Katia; Molinelli, E.; Marcucci, F.; Cascinu, Stefano; Offidani, Annamaria
A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer. 1-gen-1997 Cascinu, Stefano; R., Ficarelli; M. A., Safi; F., Graziano; G., Catalano; Cellerino, Riccardo
A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma. 1-gen-1996 Cascinu, Stefano; E. D., Ferro; M., Ligi; G., Catalano
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). 1-gen-1999 Cascinu, Stefano; G., Gasparini; V., Catalano; R. R., Silva; G., Pancera; A., Morabito; P., Giordani; D., Gattuso; G., Catalano
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer. 1-gen-1996 A., Piga; Cascinu, Stefano; L., Latini; M., Marcellini; M., Bavosi; L., Acito; R., Bascioni; L., Giustini; G., Francini; A., Pancotti; G., Rossi; M. D., Papa; Carle, Flavia; Cellerino, Riccardo
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 1-gen-2012 G., Gasparini; F., Torino; T., Ueno; Cascinu, Stefano; T., Troiani; A., Ballestrero; Berardi, Rossana; J., Shishido; A., Yoshizawa; Y., Mori; S., Nagayama; P., Morosini; M., Toi
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. 1-gen-2001 Cascinu, Stefano; F., Graziano; S., Barni; R., Labianca; G., Comella; R., Casaretti; L., Frontini; V., Catalano; A. M., Baldelli; G., Catalano
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer. 1-gen-1999 Cascinu, Stefano; R. R., Silva; R., Labianca; S., Barni; R., Mattioli; G., Martignoni; L., Frontini; G., Gasparini; V., Catalano; A. M., Baldelli; L., Giuliodori; R., Agostinelli; G., Catalano
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. 1-gen-2003 F., Graziano; D., Santini; E., Testa; V., Catalano; G. D., Beretta; S., Mosconi; G., Tonini; V., Lai; R., Labianca; Cascinu, Stefano
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer. 1-gen-2000 F., Graziano; V., Catalano; A. M., Baldelli; P., Giordani; E., Testa; V., Lai; G., Catalano; N., Battelli; Cascinu, Stefano
A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. 1-gen-1995 Cascinu, Stefano; E. D., Ferro; G., Catalano
A randomized, double blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel. 1-gen-2013 P., Maison Blanche; J. B., Vermorken; T., Goksel; J., Machiels; S., Agarwala; S., Rottey; G., Daugaard; C., Volovat; M., Scheulen; L., Sengeløv; D., Grecea; A., Eniu; E., Jäger; E., Meiri; Cascinu, Stefano; D., Strumberg; G., Demir; M., Clemens; G., Pinotti; M., Nardi; T., Guthrie; E., Boelle; E., Magherini
Adjuvant chemotherapy in colon cancer: can we improve quality of care? 1-gen-2013 Cascinu, Stefano